Nobivac Canine 3-DAPv Vaccine

Supplied By: Merck (006772)


SKU
029018


Unit of
Measure 25 x 1 Dose


Pack
Type Box


Case
Qty 1

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023 Jun- 2023 May- 2023 Apr- 2023
{{purchaseHistoryItem}}


SKU 029018


Size 25 x 1 Dose

Case
Qty 1

Purchase History

Apr- 2024 {{productPurchaseHistory['029018'][0]}} Sep- 2023 {{productPurchaseHistory['029018'][0+7]}}
Mar- 2024 {{productPurchaseHistory['029018'][1]}} Aug- 2023 {{productPurchaseHistory['029018'][1+7]}}
Feb- 2024 {{productPurchaseHistory['029018'][2]}} Jul- 2023 {{productPurchaseHistory['029018'][2+7]}}
Jan- 2024 {{productPurchaseHistory['029018'][3]}} Jun- 2023 {{productPurchaseHistory['029018'][3+7]}}
Dec- 2023 {{productPurchaseHistory['029018'][4]}} May- 2023 {{productPurchaseHistory['029018'][4+7]}}
Nov- 2023 {{productPurchaseHistory['029018'][5]}} Apr- 2023 {{productPurchaseHistory['029018'][5+7]}}
Oct- 2023 {{productPurchaseHistory['029018'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

A proven 3-year vaccine that offers comprehensive protection against 4 highly contagious canine viruses.

Features & Benefits

  • Challenge studies in dogs showed 100% protection over 3 years against distemper, adenovirus, and parvovirus
  • Used formulation containing CPV STRAIN 154®, able to override maternal antibodies at an early age
  • Serologic tests demonstrated high antibody titers throughout the 3-year post-vaccination isolation period
  • Manhattan strain of CAV-2 was used to confer protection against canine infectious hepatitis caused by canine adenovirus type 1 (CAV-1) without eliciting the adverse reactions associated with CAV-1 vaccines
  • Protects against the commonly spread canine distemper virus
  • Protects against all field strains of CPV currently seen
  • Prevents both infectious canine hepatitis caused by CAV-1 and infectious tracheobronchitis associated with CAV-2